PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC
Clinical trial NCT04144569 · RECRUITING
Trial details
- NCT number
- NCT04144569
- Sponsor
- Yongchang Zhang
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2024-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.